4//SEC Filing
ROSS GEORGE K 4
Accession 0001104659-20-001557
CIK 0000786947other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:36 PM ET
Size
14.5 KB
Accession
0001104659-20-001557
Insider Transaction Report
Form 4
ROSS GEORGE K
Director
Transactions
- Exercise/Conversion
Common Stock
2020-01-02+50,000→ 261,005 total - Tax Payment
Common Stock
2020-01-02$0.23/sh−3,624$834→ 257,381 total - Exercise/Conversion
Restricted Stock Units (2017 Plan)
2020-01-02+50,000→ 33,333 total→ Common Stock (50,000 underlying) - Disposition to Issuer
Restricted Stock Units (2017 Plan)
2020-01-02$0.23/sh−33,333$7,667→ 0 total→ Common Stock (33,333 underlying) - Award
Restricted Stock Units (2017 Plan)
2020-01-02+54,790→ 54,790 total→ Common Stock (54,790 underlying)
Footnotes (9)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]83,333 Restricted Stock Units were granted on the first business day of January 2019. 25% of Restricted Stock Units vested on March 31, 2019, 25% vested on June 30, 2019; 25% vested on September 30, 2019 and 25% vested on December 31, 2019. 40% of such Restricted Stock Units are being settled in cash and 60% are being settled on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2020, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2021, or earlier upon a change of control.
- [F8]For payment of par value of $0.01 per share.
- [F9]Does not include par value of $0.01 per share that must be paid or deducted upon exchange for cash.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001068724
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:36 PM ET
- Size
- 14.5 KB